"It is time to challenge current treatment practices—namely, using inhibitors and
antagonists alone—and to develop immunoresolvents as agonists of resolution pharmacology."

- Professor Charles Serhan, Harvard Medical School. FASEB J (2017).

Resolvins: Agonists of Inflammation Resolution

Discovered by Dr. Serhan and his colleagues at Harvard, Resolvins are a novel class of "Immunoresolvents" that resolve inflammation, enhance clearance of debris (phagocytosis), and promote healing. Unlike standard anti-inflammatory drugs that inhibit immune function, Resolvins are agonists of resolution that restore homeostasis without immune suppression.

Our Technology

Our HEALER technology transforms Resolvins into new molecules with enhanced stability and formulation properties to enable their pharmaceutical development as small molecules with composition of matter patent protection.